Oryn Therapeutics
Biotechnology; Research
Oryn Therapeutics is a clinical-stage company developing a new class of drug candidates, Orynotides. These proprietary drug candidates are uniquely engineered, stable, macrocyclic peptides with very low immunogenicity and favorable safety profile. They modulate pathologic inflammatory diseases and hold the ability to restore the immune homeostasis.
Open Positions at Oryn Therapeutics
0 positions available
No open positions at the moment
Check back later for new opportunities!